Effect of bretylium tosylate on the prevention and treatment of postoperative arrhythmias.
D000368:Aged; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000517:prevention & control*; D001794:Blood Pressure / Q000187:drug effects; D001949:Bretylium Compounds / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006348:Cardiac Surgical Procedures / Q000009:adverse effects*; D002395:Catecholamines / Q000627:therapeutic use; D004554:Electric Countershock; D006350:Heart Valve Prosthesis; D006801:Humans; D008297:Male; D011183:Postoperative Complications / Q000517:prevention & control*; D013610:Tachycardia / Q000517:prevention & control; D013997:Time Factors; D014693:Ventricular Fibrillation / Q000517:prevention & control; D014839:Vomiting / Q000139:chemically induced
D000889:Anti-Arrhythmia Agents; D001949:Bretylium Compounds; D002395:Catecholamines